 AUSTIN, Texas--BUSINESS WIRE--Savara Inc. Nasdaq: SVRA, a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that Savara management will be presenting at the Oppenheimer Rare Orphan Disease Virtual Summit on Friday, May 21, 2021 at 12:25 PM ET 9:25 AM PT. Interested parties can access a live audio webcast on the Investors page of the Savara website at Please connect to the Companys web 